Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-026-2 | CAS number: 102-36-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute toxicity via Oral route: Female rat LD50 = 91 mg/kg bw (Key, Rel.2).
Acute toxicity via Inhalation route: LC50 = 0.338 mg/L (Key, Rel.2)
Acute toxicity via Dermal route: Combined LD50 > 2000 mg/kg bw (Key, Rel2).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: scientific acceptable
- Principles of method if other than guideline:
- 3,4-dichlorophenyl isocyanate was diluted with Lutrol and administered, by intubation, to rats. The animals were given a volume equivalent to 0.5% of their body weight. Four groups of 5 males were given dose levels of 201, 342, 582 and 990 mg/kg and four groups of 5 females were given 41, 70, 118 and 201 mg/kg
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Doses:
- male: 201, 342, 582 and 990 mg/kg bw
female: 41, 79, 118 and 201 mg/kg bw - No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 402 mg/kg bw
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 91 mg/kg bw
- Mortality:
- male:
201 mg/kg: 0/5/5 (deaths/symptoms/no. exposed)
342 mg/kg: 2/5/5
582 mg/kg: 4/5/5
990 mg/kg: 5/5/5
female:
41 mg/kg: 1/5/5 (deaths/symptoms/no. exposed)
70 mg/kg: 0/5/5
118 mg/kg: 5/5/5
201 mg/kg: 4/5/5 - Clinical signs:
- other: lethargy, pilo erection, convulsions at high dose levels - all death occured within 24 hours post-treatment
- Gross pathology:
- gastrointestinal inflammation
- Interpretation of results:
- Category 3 based on GHS criteria
- Executive summary:
method: 3,4 -Dichlorophenyl isocyanate was diluted with Lutrol and administered, by intubation, to rats. The animals were given a volume equivalent to 0.5% of their body weight. Four groups of 5 males were given dose levels of 201, 342, 582 and 990 mg/kg and four groups of 5 females were given 41, 70, 118 and 201 mg/kg.
result: LD50(male) = 402 mg/kg bw; LD50(female) = 91 mg/kg bw
Reference
no data
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 91 mg/kg bw
- Quality of whole database:
- Three studies are available, all being pre-GLP and pre-guidelines. As a worst-case, the study giving the lowest LD50 value was selected as the key study.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: guidelinestudy
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- other: unchanged (no vehicle)
- Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 0, 91.7, 97.4, 150.7, 255.5, 452.3 mg/m³
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Sex:
- female
- Dose descriptor:
- LC50
- Effect level:
- 338 mg/m³ air
- Exp. duration:
- 4 h
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 452 mg/m³ air
- Exp. duration:
- 4 h
- Mortality:
- male:
control 0/0/10
91.7 mg/m³ 0/0/5
97.4 mg/m³ 0/5/5
150.7 mg/m³ 0/5/5
255.5 mg/m³ 0/5/5
452.3 mg/m³ 1/5/5
female:
control 0/0/10
91.7 mg/m³ 0/0/5
97.4 mg/m³ 0/5/5
150.7 mg/m³ 1/5/5
255.5 mg/m³ 2/5/5
452.3 mg/m³ 3/5/5 - Clinical signs:
- other: up to and including 91.7 mg/kg no symptoms, >= 97.4 mg/m³ laboured breathing, bloddy and serous effluent of nose, reduced motility, ruffled coat, cyanosis, tachypnoe
- Body weight:
- loss of body weight
- Gross pathology:
- up to and including 97.4 mg/m³ no significant pulmonary change. animals which died during post observation period: inflated lung, liver, spleen and kidneys were pale, bloody content of gastro-intestinal tract, reddened intestine mucosa, hydrothorax and edema of the lung
- Interpretation of results:
- Category 2 based on GHS criteria
- Executive summary:
Rats were exposed nose/head to 0, 91.7, 97.4, 150.7, 255.5, 452.3 mg/m³ 3,4 -dichlorophenyl isocyanate during 4 h. LC50 (male) > 452 mg/m³. LC50 (female) = 338 mg/m³.
Animals treated with 91.7 mg/m³ showed no clinical symptoms and no significant pathological pulmonary change. Therefore 91 mg/m³ is considered as the NOAEL. A pronounced irritational potential of the substance to the respiratory system was found
Reference
no data
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 338 mg/m³ air
- Physical form:
- inhalation: aerosol
- Quality of whole database:
- Inconsistent results were also obtained from the acute inhalation toxicity studies. The results obtained by Pauluhn (1988) was considered to be the most reliable due to methological deficiences or non-linear dose depency noted on the other studies.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: well documented and scientifically acceptable
- Principles of method if other than guideline:
- Backs of 2 male and 2 female rabbits were shaved. Compound was applied undiluted to the skin at a dose level of 2000 mg/kg. The test area was loosely covered with plastic. After 24 hours, wrappings were removed and test areas cleaned. Animals were observed 14 days for symptoms and mortality
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- male/female
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 2
- Control animals:
- not specified
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- no death occured
- Clinical signs:
- other: no symptoms occured
- Gross pathology:
- at the time of sacrifice, a gross necropsy revealed a darkened ring at the base of the cortex of the kidneys, grainy texture of the liver, and lungs with edema and small hemorrhagic areas.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information
- Executive summary:
Backs of 2 male and 2 female rabbits were shaved. Compound was applied undiluted to the skin at a dose level of 2000 mg/kg. The test area was loosely covered with plastic. After 24 hours, wrappings were removed and test areas cleaned. Animals were observed 14 days for symptoms and mortality. LD50 > 2000 mg/kg bw.
Reference
The dermal toxicity for male and female rabbits was greated than 2000 milligram per kilogram. No symptoms or death occurred over a 14 -day observation period. At the time of sacrifice, a gross necropsy revealed a darkened ring at the base of the cortex of the kidneys, grainy texture of the liver, and lungs with edema and small hemorrhagic areas. Other internal organs appeared normal.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- >= 2 000 mg/kg bw
- Quality of whole database:
- Two studies are available, both being pre-GLP and pre-guidelines. The study of Lamb (1975) was identified as the key study as it well-documented and scientifically acceptable.
Additional information
- Acute toxicity via Oral route:
Three studies are available. In one study a LD50 = 91 mg/kg bw for rat (female) and a LD50 = 402 mg/kg bw rat (male) was found (Lamb, 1975), in another study a LD50 > 2500 mg/kg bw was found (Hoechst, 1974) and in a third study a LD50 = 9921 mg/kg bw for female rats was determined (Hecht/Kimmerle, 1960). The reason for this discrepancy is unclear.
As a worst case, the study giving the lowest LD50 value was selected as the key study (91 mg/kg bw).
- Acute toxicity via Inhalation route:
Inconsistent results were also obtained from the acute inhalation toxicity studies:
1/ Pauluhn, 1988: LC50 (aerosol, nose/head-only) = 0.338 (females) to 0.452 mg/L/4 hours (males);
2/ Brown, 1968: LC50 (aerosol of melted substance, whole body) = 2.70 mg/L/4 hours (male rats);
3/ Lamb, 1975: LC100 (vapour, whole body) LC100 < 0.22 mg/L/6 hours;
4/ Hofman, 1989: LC50 (vapour of melted substance, nose-only) = 0.102 mg/L/4 hours (male rats) ;
5/ Marhold, 1986: LC50 (unspecified route of administration) = 0.140 mg/L/2 hours (rats).
The results obtained by Pauluhn was considered to be the most reliable due to methological deficiences or non-linear dose depency noted on the other studies. The key result selected is thus 0.338 mg/L.
- Acute toxicity vie Dermal route:
The LD50 for dermal application on rabbits was > 2000 mg/kg bw (Lamb, 1975).
Justification for classification or non-classification
Harmonised classification:
The substance has no harmonised classification for acute toxicity according to the Regulation (EC) No. 1272/2008 (CLP).
Self classification:
Acute toxicity via Oral route:
Based on the available information, the substance is for Acute Toxicity Category 3 (H301: Toxic if swallowed) according to the CLP and the GHS as the LD50 is 91 mg/kg bw (between 50 and 300 mg/kg bw).
Acute toxicity via Dermal route:
Based on the available information, the test item is
- not classified according to the CLP as the LD50 is greater than 2000 mg/kg bw
- not classified according to the GHS as the LD50 is greater than 2000 mg/kg bw and reliable evidence do not indicate the LD50 to be in the range of Category 5 values.
Acute toxicity via Inhalation:
Based on the available information, the substance is for Acute Toxicity Category 2 (H330: Fatal if inhaled) according to the CLP and the GHS as the LC50 is 0.338 mg/L (between 0.05 and 0.5 mg/L, aerosol).
Specific target organ toxicity: single exposure (Oral):
The classification criteria according to the CLP and to the GHS as specific target organ toxicant (STOT) – single exposure, oral are not met since no reversible or irreversible adverse health effects were observed immediately or delayed after exposure and no effects were observed at the guidance value (oral) for a Category 1 classification (C≤ 300 mg/kg bw) and at the guidance value (oral) for a Category 2 classification (2000 mg/kg bw≥C > 300 mg/kg bw). No classification is required.
The criteria for Transient Organ effects (STOT-SE Category 3) according to the CLP and to the GHS are not met since narcotic effects were not observed in the acute oral toxicity studies.
Specific target organ toxicity: single exposure (Dermal):
The classification criteria according to the CLP and the GHS as specific target organ toxicant (STOT) – single exposure, dermal are not met since no reversible or irreversible adverse health effects were observed immediately or delayed after exposure and no effects were observed at the guidance value (dermal) for a Category 1 classification (C ≤ 1000 mg/kg bw) and at the guidance value (dermal) for a Category 2 classification (2000 mg/kg bw ≥ C > 1000 mg/kg bw). No classification is required.
The criteria for Transient Organ effects (STOT-SE Category 3) according to the CLP and to the GHS are not met since narcotic effects were not observed in the acute dermal toxicity studies.
Specific target organ toxicity: single exposure (Inhalation):
The classification criteria according to the CLP and to the GHS as specific target organ toxicant (STOT) – single exposure, inhalation are not met since no reversible or irreversible adverse health effects were observed immediately or delayed after exposure and no effects were observed at the guidance value (inhalation / aerosol) for a Category 1 classification (C≤ 1.0 mg/L/4h) and at the guidance value (inhalation / aerosol) for a Category 2 classification (5.0 mgL/4h ≥C > 1.0 mg/l/4h). No classification is required.
The criteria for Transient Organ effects (STOT-SE Category 3) according to the CLP and to the GHS are not met since narcotic effects were not observed in the acute inhalation toxicity studies.
Aspiration hazard:
The substance is not a hydrocarbon and no effects were observed on lungs in oral studies, therefore the criteria for aspiration toxicity according to the CLP and to the GHS are not met.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.